Correlation Between Hemogenyx Pharmaceuticals and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Hemogenyx Pharmaceuticals and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hemogenyx Pharmaceuticals and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hemogenyx Pharmaceuticals Plc and Cue Biopharma, you can compare the effects of market volatilities on Hemogenyx Pharmaceuticals and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hemogenyx Pharmaceuticals with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hemogenyx Pharmaceuticals and Cue Biopharma.
Diversification Opportunities for Hemogenyx Pharmaceuticals and Cue Biopharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Hemogenyx and Cue is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Hemogenyx Pharmaceuticals Plc and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Hemogenyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hemogenyx Pharmaceuticals Plc are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Hemogenyx Pharmaceuticals i.e., Hemogenyx Pharmaceuticals and Cue Biopharma go up and down completely randomly.
Pair Corralation between Hemogenyx Pharmaceuticals and Cue Biopharma
Assuming the 90 days horizon Hemogenyx Pharmaceuticals Plc is expected to under-perform the Cue Biopharma. But the pink sheet apears to be less risky and, when comparing its historical volatility, Hemogenyx Pharmaceuticals Plc is 1.08 times less risky than Cue Biopharma. The pink sheet trades about -0.13 of its potential returns per unit of risk. The Cue Biopharma is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 163.00 in Cue Biopharma on August 29, 2024 and sell it today you would lose (54.00) from holding Cue Biopharma or give up 33.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hemogenyx Pharmaceuticals Plc vs. Cue Biopharma
Performance |
| Timeline |
| Hemogenyx Pharmaceuticals |
| Cue Biopharma |
Hemogenyx Pharmaceuticals and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hemogenyx Pharmaceuticals and Cue Biopharma
The main advantage of trading using opposite Hemogenyx Pharmaceuticals and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hemogenyx Pharmaceuticals position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.The idea behind Hemogenyx Pharmaceuticals Plc and Cue Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Transaction History View history of all your transactions and understand their impact on performance |